Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Individual Patient Data Validation of the EAU Definitions of BCG Failure in Patients with Non-muscle-invasive Urothelial Carcinoma of the Bladder: An International Multicenter Retrospective Study.

European urology oncology·2026
Same author

Impact of intravesical BCG Therapy on quality of life in non-muscle-invasive bladder cancer: a prospective evaluation using the FACT-Bl questionnaire.

Actas urologicas espanolas·2026
Same author

Efficacy and safety of active surveillance and chemoablation in the management of non-muscle invasive bladder cancer (NMIBC): Systematic review and pooled analysis by the European Association of Urology-Young Academic Urologists: Urothelial Carcinoma Working Group.

Actas urologicas espanolas·2026
Same author

Influence of secretome from porcine cardiosphere-derived cells on porcine macrophage polarization and their possible implications for cardiac remodeling post-myocardial infarction <i>in vitro</i>.

Frontiers in cell and developmental biology·2025
Same author

Novel risk factors for venous thromboembolism following outpatient or inpatient transurethral resection of bladder tumors: Multivariable stepwise and LASSO regression modeling from us insurance claim database.

Actas urologicas espanolas·2025
Same author

Impact of opium on bladder cancer incidence: A systematic review and meta-analysis.

Actas urologicas espanolas·2025
Same journal

Bladder Foreign Body of Gastrointestinal Origin: A Case Report and Literature Review.

Archivos espanoles de urologia·2026
Same journal

Real-Time Shear Wave Elastography Combined With MRI-Ultrasound Cognitive Fusion Targeted Biopsy for Repeat Prostate Biopsy.

Archivos espanoles de urologia·2026
Same journal

Evaluating a DeepSeek-Based Case-Based Learning Approach for Teaching the Emergency Management of Urosepsis to Nursing Students.

Archivos espanoles de urologia·2026
Same journal

Association of Fibrosis-Related Gene Expression Profiles in Benign Ureteral Stricture Tissue With Restenosis After Ureteroplasty.

Archivos espanoles de urologia·2026
Same journal

Retrospective Comparison of Transurethral Prostatic Columnar Water Balloon Dilation and Pharmacotherapy for Moderate-to-Severe Benign Prostatic Hyperplasia: Efficacy, Safety and Compliance.

Archivos espanoles de urologia·2026
Same journal

Analysis of the Effect of Stepwise Refined Nursing on the Severity of Ureteral Stent-Related Symptom Clusters After Flexible Ureteroscopic Lithotripsy.

Archivos espanoles de urologia·2026
See all related articles

Related Experiment Video

Updated: Mar 13, 2026

Surgical Model for Single-Staged Tissue-Engineered Urothelial Tubes in Minipigs
04:05

Surgical Model for Single-Staged Tissue-Engineered Urothelial Tubes in Minipigs

Published on: July 5, 2024

802

[Biodegradable catheters and urinary stents. When?]

F Soria1, E Morcillo1, A López de Alda2

  • 1Unidad de Endoscopia de la Fundación Centro de Cirugía de Mínima Invasión Jesús Usón. Cáceres. España.

Archivos Espanoles De Urologia
|October 12, 2016
PubMed
Summary
This summary is machine-generated.

Biodegradable urinary catheters and stents offer improved biocompatibility and controlled degradation, reducing complications like infection and morbidity. Ongoing bioengineering advances promise safer, more effective biodegradable devices for urological applications.

More Related Videos

An In Vitro Bladder Model of Catheter-Associated Urinary Tract Infection
07:57

An In Vitro Bladder Model of Catheter-Associated Urinary Tract Infection

Published on: June 24, 2025

1.4K
Author Spotlight: Enhancing Candida albicans Detection in Catheter Infections Using Fluorescent Protein Tagging
03:24

Author Spotlight: Enhancing Candida albicans Detection in Catheter Infections Using Fluorescent Protein Tagging

Published on: March 22, 2024

2.2K

Related Experiment Videos

Last Updated: Mar 13, 2026

Surgical Model for Single-Staged Tissue-Engineered Urothelial Tubes in Minipigs
04:05

Surgical Model for Single-Staged Tissue-Engineered Urothelial Tubes in Minipigs

Published on: July 5, 2024

802
An In Vitro Bladder Model of Catheter-Associated Urinary Tract Infection
07:57

An In Vitro Bladder Model of Catheter-Associated Urinary Tract Infection

Published on: June 24, 2025

1.4K
Author Spotlight: Enhancing Candida albicans Detection in Catheter Infections Using Fluorescent Protein Tagging
03:24

Author Spotlight: Enhancing Candida albicans Detection in Catheter Infections Using Fluorescent Protein Tagging

Published on: March 22, 2024

2.2K

Area of Science:

  • Biomaterials Science
  • Urology
  • Bioengineering

Background:

  • Permanent urinary catheters and stents can cause adverse effects, device failure, and complications like forgotten catheter syndrome.
  • There is a significant need for biodegradable alternatives to improve patient outcomes and reduce morbidity associated with urological devices.

Purpose of the Study:

  • To review recent advances in biodegradable ureteral and urethral devices.
  • To highlight challenges and future directions in developing safe and effective biodegradable urinary catheters and stents.

Main Methods:

  • Development of novel biomaterials and copolymers for controlled degradation rates.
  • Design modifications to ensure controlled, proximal-to-distal degradation and minimize fragmentation.
  • Investigation of drug-eluting and biocoated stent technologies to mitigate adverse effects.

Main Results:

  • Biodegradable materials allow programmable degradation times, enhancing biocompatibility and adaptation to urine.
  • New designs facilitate controlled degradation, reducing fragmentation and potentially lowering risks of urinary tract infection and encrustation.
  • While degradation is modulated, urothelial hyperplasia remains a challenge in biodegradable urethral stents.

Conclusions:

  • Biodegradable urinary devices show promise in reducing catheter morbidity and adverse effects.
  • Further bioengineering innovations, including drug-eluting and biocoated technologies, are crucial for overcoming challenges like urothelial hyperplasia.
  • Advances in bioengineering are paving the way for safe and effective biodegradable solutions in urology.